Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.95 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.95 |
| ▸ | F3 | P13726 | 3/20 | 0.95 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.95 |
| ▸ | PLIN1 | O60240 | 2/20 | 0.95 |
| ▸ | LMNA | P02545 | 2/20 | 0.95 |
| ▸ | RECQL | P46063 | 2/20 | 0.95 |
| ▸ | PLIN5 | Q00G26 | 2/20 | 0.95 |
| ▸ | ABHD5 | Q8WTS1 | 2/20 | 0.95 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.95 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.95 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.95 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.70 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.70 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.70 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.70 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.70 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.70 |
| ▸ | TNKS | O95271 | 1/20 | 0.70 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL546073 | 1.00 | MAPT (0.95) | MAPTCYP2C9F3CYP1A2PLIN1 | |
| SCHEMBL7512289 | 1.00 | MAPT (0.95) | MAPTCYP2C9F3CYP1A2PLIN1 | |
| SCHEMBL509571 | 1.00 | MAPT (0.95) | MAPTCYP2C9F3CYP1A2PLIN1 | |
| SCHEMBL1646390 | 1.00 | MAPT (0.95) | MAPTCYP2C9F3CYP1A2PLIN1 | |
| SCHEMBL5111 | 1.00 | MAPT (0.95) | MAPTCYP2C9F3CYP1A2PLIN1 | |
| SCHEMBL14832106 | 1.00 | MAPT (0.95) | MAPTCYP2C9F3CYP1A2PLIN1 | |
| SCHEMBL2438441 | 1.00 | MAPT (0.95) | MAPTCYP2C9F3CYP1A2PLIN1 | |
| SCHEMBL18039478 | 1.00 | MAPT (0.95) | MAPTCYP2C9F3CYP1A2PLIN1 | |
| SCHEMBL21879664 | 1.00 | MAPT (0.95) | MAPTCYP2C9F3CYP1A2PLIN1 | |
| SCHEMBL2639578 | 1.00 | MAPT (0.95) | MAPTCYP2C9F3CYP1A2PLIN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1396 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12577236-B2 | Processes for preparation of Tezacaftor | LAURUS LABS LIMITED (IN) | 2026-03-17 | — | — | US | claimed |
| EP-4656639-A1 | METHOD FOR THE PREPARATION OF IBOGAMINE AND PURIFICATION OF IBOGAMINE AND IBOGAMINE-TYPE COMPOUNDS | Oeri, Hans (CA) | 2025-12-03 | — | — | EP | claimed |
| EP-4624453-A1 | METHOD FOR PREPARING CYCLOSULFONONE, AND INTERMEDIATES | Lansheng Biotechnology Group Co., Ltd (CN) | 2025-10-01 | — | — | EP | claimed |
| EP-4568984-A1 | PROCESS FOR MANUFACTURING AN ANTIBIOTIC MACROCYCLIC PEPTIDE | F. Hoffmann-La Roche AG (CH) | 2025-06-18 | — | — | EP | claimed |
| WO-2024033278-A1 | PROCESS FOR MANUFACTURING AN ANTIBIOTIC MACROCYCLIC PEPTIDE | F. HOFFMANN-LA ROCHE AG (CH) | 2024-02-15 | — | — | WO | claimed |
| US-11713286-B2 | Butadiene telomerization catalyst preparation and use thereof | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-08-01 | — | — | US | claimed |
| CN-116217395-A | Preparation method of beta-carbonyl compound | 黄淮学院 | 2023-06-06 | — | — | CN | claimed |
| US-20220298097-A1 | METHOD FOR PREPARING ORGANIC CARBOXYLIC ESTER BY USING COMBINED CATALYST OF ARYL BIDENTATE PHOSPHINE LIGAND | NANJING CHENGZHI CLEAN ENERGY CO. LTD. (CN) | 2022-09-22 | — | — | US | claimed |
| US-20220213006-A1 | BUTADIENE TELOMERIZATION CATALYST PREPARATION AND USE THEREOF | DOW GLOBAL TECHNOLOGIES LLC (US) | 2022-07-07 | — | — | US | claimed |
| US-11345700-B2 | Methods of preparing inhibitors of influenza viruses replication | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2022-05-31 | — | — | US | claimed |
| US-20090282730-A1 | METHOD AND COMPOSITION FOR IMPROVING FUEL COMBUSTION | CARROLL & ASSOCIATES LLC | 2009-11-19 | — | — | US | claimed |
| EP-2093275-A2 | Method and composition for improving fuel combustion | Carroll & Associates LLC (US) | 2009-08-26 | — | — | EP | claimed |
| US-20080287663-A1 | Process For Production Of 4-Biphenylyazetidin-2-Ones | MICROBIA, INC. (US) | 2008-11-20 | — | — | US | claimed |
| EP-1893571-A2 | PROCESS FOR PRODUCTION OF 4-BIPHENYLYAZETIDIN-2-ONES | Microbia Inc. (US) | 2008-03-05 | — | — | EP | claimed |
| WO-2006122020-A2 | PROCESS FOR PRODUCTION OF 4-BIPHENYLYAZETIDIN-2-ONES | MICROBIA, INC. (US) | 2006-11-16 | — | — | WO | claimed |
| WO-2005058813-A2 | THIODIAZOLIDINEDIONE, OXAZOLIDINEDIONE AND DIAZOLIDINEDIONE DERIVATIVES AND THEIR USE AS ANTIDIABETIC AGENTS | RANBAXY LABORATORIES LIMITED (IN) | 2005-06-30 | — | — | WO | claimed |
| EP-1259475-A4 | TRANSITION METAL-CATALYZED PROCESS FOR ADDITION OF AMINES TO CARBON-CARBON DOUBLE BONDS | UNIV YALE (US) | 2004-08-18 | — | — | EP | claimed |
| EP-1259475-A1 | TRANSITION METAL-CATALYZED PROCESS FOR ADDITION OF AMINES TO CARBON-CARBON DOUBLE BONDS | YALE UNIVERSITY (US) | 2002-11-27 | — | — | EP | claimed |
| US-6384282-B2 | CATALYST IS REACTION PRODUCT OF GROUP 8 METAL AND LIGAND | YALE UNIVERSITY | 2002-05-07 | — | — | US | claimed |
| WO-2001064620-A1 | TRANSITION METAL-CATALYZED PROCESS FOR ADDITION OF AMINES TO CARBON-CARBON DOUBLE BONDS | YALE UNIVERSITY (US) | 2001-09-07 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080287663-A1 | Process For Production Of 4-Biphenylyazetidin-2-Ones | CYP4Z1, CYP4F12, CYP4F2 | MAPT 4071/4885CYP2C9 64/4885F3 1073/4885 |
| US-11713286-B2 | Butadiene telomerization catalyst preparation and use thereof | TELO2, TERT, TPR | MAPT 1556/4885CYP2C9 2654/4885F3 3475/4885 |
| US-12577236-B2 | Processes for preparation of Tezacaftor | CYP4A11, F9, CYP3A4 | MAPT 3497/4885CYP2C9 23/4885F3 43/4885 |
| US-20220213006-A1 | BUTADIENE TELOMERIZATION CATALYST PREPARATION AND USE THEREOF | TELO2, TERT, TPR | MAPT 1556/4885CYP2C9 2654/4885F3 3475/4885 |
| US-20220298097-A1 | METHOD FOR PREPARING ORGANIC CARBOXYLIC ESTER BY USING COMBINED CATALYST OF ARYL BIDENTATE PHOSPHINE LIGAND | POF1B, ADH1C, OSBP | MAPT 4032/4885CYP2C9 240/4885F3 2505/4885 |
| US-11345700-B2 | Methods of preparing inhibitors of influenza viruses replication | ZC3HAV1, ZC3HAV1L, POLR2H | MAPT 3742/4885CYP2C9 1699/4885F3 865/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.